Sponsor Pipeline

Ionis Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
24
Active Trials
11
Recruiting
12
Phase 3
2
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07298447
Donidalorsen Treatment in Children With Hereditary Angioedema
Trial sites expanded: 10 -> 13 locations
2026-07-30 NCT04850105
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Enrollment closed, study ongoing
2026-07-30 NCT04850105
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Enrollment reduced: 240 -> 202 participants
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-27 NCT07727538 A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in… Phase 3 Recruiting
Active Trials by Phase
Phase 3
12
Phase 2
1
Phase 1/2
4
Phase 1
2
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07727538 A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in… Familial Chylomicronemia Syndrome Recruiting
NCT07298447 Donidalorsen Treatment in Children With Hereditary Angioedema Hereditary Angioedema (HAE) Recruiting
NCT06914609 REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome Angelman Syndrome Recruiting
NCT04136171 CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly… Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Active, Not Recruiting
NCT05681351 CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants… Severe Hypertriglyceridemia Active, Not Recruiting
NCT05071300 A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as… Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Active, Not Recruiting
NCT05130450 A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial… Familial Chylomicronemia Syndrome Active, Not Recruiting
NCT05185843 A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With… Familial Chylomicronemia Syndrome Active, Not Recruiting
NCT05392114 A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic… Hereditary Angioedema Active, Not Recruiting
NCT04849741 A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With… Alexander Disease Active, Not Recruiting
NCT05667493 An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With… Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Enrolling by Invitation
NCT04768972 FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics… Amyotrophic Lateral Sclerosis Active, Not Recruiting
Phase 2
NCT07604974 A Study to Assess the Safety, Tolerability and Efficacy of ION775 Hypertriglyceridemia Recruiting
Phase 1/2
NCT05127226 HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple… Angelman Syndrome Recruiting
NCT06430385 ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and… Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome Recruiting
NCT06153966 PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and… Prion Disease Recruiting
NCT07531745 ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome Dravet Syndrome Recruiting
Phase 1
NCT06150716 Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of… Pelizaeus-Merzbacher Disease Recruiting
NCT04165486 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered… Multiple System Atrophy Recruiting
Not specified
NCT05659901 Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants… Pelizaeus-Merzbacher Disease Recruiting
NCT04270058 TEGSEDI Pregnancy Surveillance Program Hereditary Transthyretin-mediated Amyloidosis With Polyneropathy Not Yet Recruiting
NCT06073574 CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Active, Not Recruiting
NCT06073587 The CARDIO-TTRansform Scintigraphy Sub-study Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Active, Not Recruiting
NCT04850105 A Non-interventional Cohort Safety Study of Patients With hATTR-PN Hereditary Transthyretin Amyloidosis With Polyneuropthy Active, Not Recruiting
Disease Areas
Get alerts when Ionis Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free